0.00Open0.05Pre Close0 Volume611 Open Interest4975.00Strike Price0.00Turnover442.35%IV10.64%PremiumApr 29, 2025Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.05Extrinsic Value100Contract SizeEuropeanOptions Type-0.0009Delta0.0000Gamma111341.40Leverage Ratio-12.5551Theta0.0000Rho-99.74Eff Leverage0.0014Vega
S&P 500 Index Stock Discussion
Play by different rules
S&P 500 $S&P 500 Index (.SPX.US)$ gained +0.28%, led by Microsoft $Microsoft (MSFT.US)$ (+0.55%) and Meta $Meta Platforms (META.US)$ (+0.42%), while Tesla $Tesla (TSLA.US)$ (-1.12%) $Alphabet-A (GOOGL.US)$ and Amazon $Amazon (AMZN.US)$ (-0.40%) ...
Heck, last Monday, the day of our marketplace's most recent panicke...
On China side, he said he had no further details and wouldn't confirm if negotiations were even taking place with the country. Is he also calling his own President’s bluff?
$SPDR S&P 500 ETF (SPY.US)$ $S&P 500 Index (.SPX.US)$ $Invesco QQQ Trust (QQQ.US)$ $Strategy (MSTR.US)$ $Super Micro Computer (SMCI.US)$ $Tesla (TSLA.US)$ $NVIDIA (NVDA.US)$ $GameStop (GME.US)$ $Microsoft (MSFT.US)$ $Alphabet-A (GOOGL.US)$ $Meta Platforms (META.US)$ $SPDR Gold ETF (GLD.US)$ $Coca-Cola (KO.US)$ $Nike (NKE.US)$ $PepsiCo (PEP.US)$ $Lululemon Athletica (LULU.US)$
wake me up at 5575
$Pfizer (PFE.US)$'s stock rose Tuesday after the drug manufacturer said it's trending toward the higher end of its 2025 profit projections.
Pfizer also beat analyst expectations for first-quarter earnings as it benefited from cost-saving efforts, although it fell short of Wall Street's revenue estimate, as sales of its COVID-19 medicine Paxlovid plunged by 75% on fading demand.
"Our focus on operational efficiency and financial discipline is driving strong results to our bottom l...
No comment yet